Flagship Biosciences
PrivateLast Round
Seed
Jul 11, 2023
Total Funding Raised
$5.66M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Flagship Biosciences is a life sciences company that provides digital pathology and spatial biology services to support drug development and clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flagship Biosciences Comparables
Compare Flagship Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OracleBio | 88% | |
| Aignostics | 81% | |
| Indica Labs | 81% |
Flagship Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 11, 2023 | ||||
| Growth Equity | Aug 31, 2022 | ||||
| Debt | Feb 11, 2021 | ||||
| Debt | Apr 14, 2020 |
Key People
Founding team and executive leadership
Flagship Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Archives | Seed |
| Research Corporation Technologies | Growth Equity |
| Dream Ventures | Seed |
| AUFI Ventures | Seed |
| Essential Capital | Seed |
| Kleiner Perkins | Seed |
| Insight Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 40% MoM.
- Aug 31, 2022
BroadOak Capital Partners and Research Corporation Technologies participated.
Flagship Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Flagship Biosciences's valuation, stock price, and market status.
Is Flagship Biosciences a public or private company?
Flagship Biosciences is a private company.
What is the current stock price of Flagship Biosciences?
Flagship Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Flagship Biosciences worth (valuation)?
Valuation information for Flagship Biosciences is not publicly available.
Can I buy Flagship Biosciences stock?
Flagship Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Flagship Biosciences's last funding round?
Flagship Biosciences's most recent funding round was Seed on July 11, 2023.
Who are the main investors in Flagship Biosciences?
Key investors in Flagship Biosciences include Insight Partners.
Will Flagship Biosciences IPO soon?
No public IPO plans have been announced for Flagship Biosciences.
How can I track Flagship Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Flagship Biosciences's secondary market activity and sign up for updates.